Health News Today: GLP-1 Drugs, Cancer Risks, Relationships
This week's health news includes a study linking GLP-1 weight-loss drugs to Wernicke encephalopathy, research on cancer risks from hot beverages and alcohol, and advice for couples navigating 'food divorces' and political divides.
Health News Today: Critical Updates on Weight-Loss Drugs, Cancer Links, and Relationship Well-being September 13, 2026 – This week brings significant health news with a new study linking popular GLP-1 weight-loss medications to a rare but serious neurological disorder, alongside updated research on cancer risks associated with beverage temperature and alcohol consumption. Experts also weigh in on the growing trend of "food divorces" and offer advice for couples navigating political disagreements. GLP-1 Drugs and Wernicke Encephalopathy Risk A concerning study published this week has identified a potential link between the widely used GLP-1 receptor agonist drugs, such as Ozempic and Mounjaro, and cases of Wernicke encephalopathy. This neurological disorder, also known as vitamin B1 (thiamine) deficiency encephalopathy, can lead to severe confusion, coordination problems, and eye movement issues. Researchers reported on 15 cases where patients developed Wernicke encephalopathy while taking these medications, prompting calls for increased awareness among both patients and healthcare providers. While GLP-1 drugs have shown remarkable success in managing type 2 diabetes and promoting…